International Standard
ISO/TS 21560:2020
General requirements of tissue-engineered medical products
Reference number
ISO/TS 21560:2020
Edition 1
2020-08
International Standard
Read sample
p
ISO/TS 21560:2020
71086
Published (Edition 1, 2020)
This standard was last reviewed and confirmed in 2024. Therefore this version remains current.

ISO/TS 21560:2020

ISO/TS 21560:2020
71086
Format
Language
CHF 63
Convert Swiss francs (CHF) to your currency

Abstract

This document specifies general requirements for tissue-engineered medical products (TEMPs), which are used in regenerative medicine. With regard to safety, this document outlines requirements for materials, manufacture, quality control, and unintentional biological effects elicited by TEMPs. This document does not address requirements for clinical trials and efficacy.

This document is not applicable to tissue-engineered products used for diagnosis, ex-vivo testing or extracorporeal treatments of patients (e.g. dialysis with TEMP components). TEMPs containing viable xenogenic cells, genetically modified cells, or cells derived from abnormal cells or tissues (e.g. cancerous tissues) are also excluded from the scope. The combination of TEMPs with medical devices, with the exception of scaffolds comprised of synthetic and/or naturally-derived (e.g. animal sourced) materials, is also excluded from the scope.

NOTE International, national or regional regulations or requirements, or the Pharmacopeia also apply to specific topics covered in this document.

General information

  •  : Published
     : 2020-08
    : International Standard confirmed [90.93]
  •  : 1
     : 11
  • ISO/TC 150/SC 7
    11.040.40 
  • RSS updates

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)